×

Pradaxa: New bleeding risks, a cover-up or what?

Steve Borzak, MD By Steve Borzak, MD, FACC The British Medical Journal published several papers this week detailing concerns about the bleeding risk of pradaxa (dabigatran), a coumadin substitute used for stroke risk reduction in atrial fibrillation.  In the first article, investigative journalist Deborah Cohen…